Expression of the human immunodeficiency virus type 1 (HIV-1) Env
glycoprotein is stringently regulated in infected cells. The majority
of the glycoprotein does not reach the cell surface but rather is
retained in the endoplasmic reticulum or a cis-Golgi compartment and subsequently degraded. We here report that Env of
various HIV-1 isolates is ubiquitinated at the extracellular domain of
gp41 and that Env expression could be increased by lactacystin, a
specific proteasome inhibitor, suggesting that the ubiquitin/proteasome system is involved in control of expression and degradation.
 |
TEXT |
The human immunodeficiency virus
type 1 (HIV-1) envelope glycoprotein gp160 is produced as a precursor
polyprotein, which is cleaved in a Golgi
or post-Golgi compartment by a cellular furin-type protease into gp120
and gp41 subunits (13, 19, 22, 25, 26). Although Env
cleavage efficacy during its transport through the secretory pathway
depends on both cell type and virus isolate, it is very inefficient;
the majority of the Env glycoproteins remain uncleaved and retained in
the endoplasmic reticulum (ER) or a cis-Golgi compartment
(8). Accordingly, the majority of the gp160 glycoproteins
remain endoglycosidase H sensitive, which is indicative of proteins
that do not reach the medial Golgi (14, 27). Retained and
probably misfolded Env is subsequently degraded, which was reported to
occur in either lysosomes (31) or a Golgi-associated compartment (14). However, the current view of protein
degradation holds that lysosomes are reached through either endosomes
or late Golgi compartments.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 1.
Env from various HIV-1 subtypes is ubiquitinated. (a)
293T cells transiently transfected with Env MN were pulsed for 1 h
with [35S]Cys-Met, lysed, and precipitated with either
polyclonal antiserum U5379 against ubiquitin (Sigma, St. Louis, Mo.), a
human antiserum detecting HIV-1 Env (95-2), or an irrelevant antiserum.
Subsequently, lysates were reprecipitated with either of the three
antibodies and analysed by SDS-PAGE (8% gel) and autoradiography. The
numbers 1 and 2 refer to the sequential order of precipitation. (b)
Ubiquitinated Env of cells metabolically labeled for 1 h with
[35S]Cys-Met can be detected by precipitation using
monoclonal antibody 2C5 (Calbiochem, La Jolla, Calif.) or polyclonal
antisera SPA-200 (Stressgene, Victoria, British Columbia, Canada) and
U5379 (Sigma) against ubiquitin and reprecipitation with anti-Env. (c)
293T cells were either infected with recombinant vaccinia virus
(NIBSC/MRC AIDS Reagent Project) expressing Env of the 92UG037 (subtype
A), 92BR020 (subtype B), or 92BR025 (subtype C) isolates or transiently
transfected with a plasmid expressing Env of the MN (subtype B) isolate
(1). Cell lysates of cells metabolically labeled for 1 h with [35S]Cys-Met were either precipitated with human
antiserum 95-2 against HIV-1 or first precipitated with polyclonal
serum U5379 against ubiquitin and reprecipitated with antiserum 95-2 (derived from an HIV-1-infected individual). Immunoprecipitates were
subjected to SDS-PAGE on an 8% gel. (d) Cells transiently transfected
with Env MN were labeled for 1 h with [35S]Cys-Met,
lysed, and precipitated with either antiserum 95-2 or polyclonal
antiserum U5379 and subsequently reprecipitated with 95-2. The
immunoprecipitates were either digested with PNGase F (Roche,
Mannheim, Germany) (gp160*) overnight or left untreated (gp160)
and subjected to electrophoresis.
|
|
The ER is the entry site of proteins into the secretory pathway. It is
responsible for proper folding of proteins before transport to the
cis-Golgi compartment and acts to ensure that misfolded and
nonassembled proteins are eliminated (reviewed in references 10 and 15). Recently, the
ubiquitin/proteasome system located in the cytoplasm was identified as
the major site of degradation for ER-resident proteins as well as
proteolytic substrates of the secretory pathway destined for
degradation (3, 28). Proteolytic degradation of these
proteins appears to be preceded by a retrograde transport to the
cytosol (17, 30). Recently, it was reported that the
chaperone GRB78 BiP is linked to this retrograde protein translocation
for ER degradation (12, 18, 23). In HIV-infected cells,
GRB78 BiP was shown to bind to Env (9) together with other
ER-based chaperones including calnexin (16, 21) and calreticulin (21). As the majority of Env is retained in the ER and subsequently degraded without reaching late Golgi compartments, we asked whether the ubiquitin/proteasome system is involved in HIV-1
Env degradation and whether ubiquitinated Env can be detected in
infected cells.
First, we tested whether Env glycoprotein of the MN isolate can be
reprecipitated using antiubiquitin and anti-Env antibodies (Fig. 1a).
Upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) Env glycoprotein was detected independently of the sequential order of precipitation if antiubiquitin and anti-Env antibodies were used, but not if either of the two antibodies was
replaced by an irrelevant antibody. To exclude that cross-reactivity of
the antiubiquitin antibody caused this result, we tested three different commercially available mono- and polyclonal antibodies (Fig.
1b). As shown with Env 92BR020, all three antibodies were able to
reprecipitate Env, indicating specific recognition of the antigen.
Subsequently, we tested glycoproteins of different HIV-1 isolates
expressed by either recombinant vaccinia virus or transient
transfection with Env expression plasmids for ubiquitination (Fig. 1c).
Env glycoproteins from all HIV-1 isolates tested, including MN (subtype
B) and the primary isolates 92UG037 (subtype A), 92BR020 (subtype B),
and 92BR025 (subtype C), were found to be ubiquitinated. Moreover,
ubiquitinated Env was precipitated from 293T kidney carcinoma cells
(Fig. 1), as well as C8166 and Jurkat T lymphocytes, indicating that
ubiquitination of Env is not cell type specific (data not shown).
Although the molecular weight was difficult to evaluate due to high
glycosylation, we could detect no major differences in size between
total Env and ubiquitinated Env, suggesting that only a single
ubiquitin molecule (8.4 kDa) had been added. To evaluate the number of
ubiquitin residues linked to the glycoprotein, we treated the
immunoprecipitates with peptide N-glycosidase (PNGase F),
which completely removes carbohydrate moieties (Fig. 1d). A size
difference of approximately 8 kDa corresponding to one ubiquitin
molecule could be detected between deglycosylated total and
ubiquitinated Env. No ubiquitinated Env could be found within total
deglycosylated Env, probably reflecting the low quantity of the
ubiquitinated form in relation to total Env.
Misfolded soluble and membrane proteins in the ER are dislocated to the
cytosolic proteolytic system by retrograde transport, in which at least
for some proteins components of the Sec61 translocon and the proteasome
appear to be involved (17, 30). We thus tested by
particulate fraction experiments whether ubiquitinated Env is membrane
associated or can be found in the cytosol (Fig. 2). Transfected 293T cells were
metabolically labeled for 1 h and chased for 0 and 5 h. Cells
were disrupted and separated into membrane and cytosolic fractions by
centrifugation. After both 0 and 5 h of chase, ubiquitinated Env
was found only in the membrane (pellet), not in the cytosolic fraction
(supernatant). Due to the low Env cleavage efficiency in 293T cells,
almost no gp120 could be detected even after 5 h of chase. To
control for proper fractionation, major histocompatibility complex
(MHC) class I molecules were precipitated from both fractions. As
previously reported, MHC class I molecules were precipitated from the
membrane but not in the cytosolic fraction under the conditions used
(30). Therefore, we have no evidence for a contamination of
the two fractions and conclude that the main portion of ubiquitinated Env is still membrane bound and not located within the cytosol in
soluble form. Addition of lactacystin, a specific proteasome inhibitor,
increased the amount of both Env and ubiquitinated Env after 0 and
5 h of chase (Fig. 2). Thus, these data suggest that ubiquitinated
Env is at least partly degraded by proteasomes and that Env is
ubiquitinated prior to translocation into the cytosol.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 2.
Ubiquitinated Env is membrane associated, and its
expression is increased by proteasome inhibitors. Transiently
transfected 293T cells expressing Env MN were pulsed for 1 h with
[35S]Cys-Met and subsequently chased for 0 and 5 h.
Cells were pretreated with 5 µM lactacystin (+) or culture medium
alone ( ) for 1 h. Lactacystin was also present during the pulse
and chase periods. Cells were detached with 1 mM
EDTA-phosphate-buffered saline (PBS) and resuspended in hypotonic
buffer (10 mM HEPES, 10 mM KCl, 10 mM MgCl2 [pH 7.6]).
Subsequently, cells were disrupted using a 25-gauge syringe, nuclei
were removed by centrifugation at 1,000 × g for 10 min, and membrane (m) and cytosolic (c) fractions were isolated by
centrifugation at 20,000 × g for 15 min. The pellet
was resuspended and washed once in hypotonic buffer. The lysates were
split and either precipitated with human antiserum 95-2 against HIV-1
(a), first precipitated with a polyclonal serum against ubiquitin
(U5379) and reprecipitated with antiserum 95-2 (b), or precipitated
with a monoclonal antibody against MHC class I (W6/32) (c).
Immunoprecipitates were subjected to electrophoresis on either an 8%
(gp160) or 12% (MHC class I) gel.
|
|
Ubiquitin is usually attached to lysine residues in long polymeric
chains (7, 11) but can also be detected in
monoubiquitinated (20, 29) and in lysineless proteins
(5, 6). To determine the site of ubiquitination, C-terminal
Env deletion mutants were tested by reprecipitation with antiubiquitin
and anti-Env antibodies (Fig. 3a and b).
Ubiquitinated Env MN was detected in transfected 293T cells after a 1-h
pulse if gp160, gp140
cyt, or gp130
tm was expressed, but not for
gp120, suggesting that ubiquitin is bound to the extracellular part of
gp41. Further evidence for this binding site was received by proteinase
K digest of isolated microsomes from 293T cells expressing Env (Fig.
3c). Ubiquinated Env was detected by reprecipitation in undigested as
well as in proteinase K-digested microsomes, indicating that
proteolytic deletion of the cytoplasmic Env domain does not disrupt
ubiquitination. Since we were not able to detect the proteinase
K-digested Env protein by Western blot analysis with monoclonal
antibody 1577 directed against residues 735 to 752 of gp41, the
cytoplasmic gp41 domain had been completely degraded (Fig. 3d).
Sequence comparison between the four ubiquitinated Env glycoproteins
shown in Fig. 1 revealed three conserved lysine residues as potential
sites of ubiquitination. Our results indicating that ubiquitinated Env is still membrane associated and that ubiquitin is bound to the extracellular, luminal part of gp41 suggest that ubiquitination, translocation, and ER degradation of Env constitute an integrated process, as recently discussed for other luminal and integral membrane
proteins (4, 24). To test whether ubiquitinated Env can also
be detected in HIV-1-infected cells, we metabolically labeled C8166
cells infected with either HIV-1 MN or HIV-1 MvP 899 and reprecipitated
cell lysates with antiubiquitin and anti-Env antisera (Fig.
4). In accordance with the experiments
shown in Fig. 3, mapping the ubiquitination site, we detected
ubiquitinated gp160 but not gp120 in cells infected with both HIV-1
isolates.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 3.
The extracellular domain of gp41 is ubiquitinated. (a)
Schematic diagram of the Env MN deletion mutants used. (b) Env MN
deletion mutants were transiently transfected into 293T cells. Cell
lysates of metabolically labeled cells were either precipitated with
human antiserum 95-2 against Env or first precipitated with polyclonal
serum U5379 (Sigma) against ubiquitin and reprecipitated with antiserum
95-2. Immunoprecipitates were subjected to SDS-PAGE on an 8% gel. (c)
293T cells transiently transfected with Env MN were metabolically
labeled for 1 h. Subsequently, cells were detached with 1 mM
EDTA-PBS, washed with PBS, resuspended in lysis buffer (140 mM NaCl, 5 mM MgCl2, 20 mM Tris-HCl [pH 7.6]) without NP-40, and
homogenized in a cell homogenizer. Nondisrupted cells and nuclei were
removed by low-speed centrifugation, and microsomes were isolated by
centrifugation for 1 h at 100,000 × g. The
microsome fraction was resolved and subjected to either proteinase K
(0.4 mg/ml, final concentration) or proteinase K and NP-40 (1%)
digestion for 30 min. Full-length Env (*) or Env lacking the
cytoplasmic domain (**) was either precipitated with human
antiserum 95-2 against HIV-1 or first precipitated with a monoclonal
antibody against ubiquitin and reprecipitated with antiserum 95-2. Immunoprecipitates were subjected to SDS-PAGE on an 8% gel. (d)
Untreated, proteinase K-treated, or proteinase K- and NP40-treated
microsomal fractions were analyzed by Western blotting using human
antiserum 95-2 against Env or monoclonal antibody 1577 directed against
the cytoplasmic domain of gp41.
|
|

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 4.
gp160 is ubiquitinated in HIV-1-infected cells. C8166
cells infected with either HIV-1 MN or HIV-1 MvP 899 or mock-infected
control cells were metabolically labeled with
[35S]Cys-Met for 15 h and subsequently lysed without
chase. Cell lysates were either precipitated with human antiserum 95-2 against Env or first precipitated with polyclonal serum U5379 (Sigma)
against ubiquitin and reprecipitated with antiserum 95-2.
|
|
In this study, we showed that the extracellular domain of HIV-1 gp41 is
ubiquitinated. Since the proteasome inhibitor lactacystin increased the
amount of Env, we assume that ubiquitination occurs prior to
degradation in the proteasome. This is consistent with and might
explain observations by us and other groups that the majority of Env
molecules are retained in the ER and stay endoglycosidase H sensitive
(14, 27). Intriguingly, recent reports suggested alternative
explanations for ubiquitinated viral proteins. It was shown that
p6gag of HIV-1 and simian immunodeficiency
virus, as well as p12gag of murine leukemia
virus and US9 of herpes simplex virus type, 1 are ubiquitinated and can
be found within virus particles, in addition to free ubiquitin (2,
5, 20). The significance of ubiquitinated viral proteins thus
remains unclear. Ubiquitinated viral proteins might have escaped from
degradation by the proteasome in cells with high levels of viral
proteins. Alternatively, it has been suggested that ubiquitinated viral
proteins have specific roles in viral pathogenesis using the host cell
ubiquitin/proteasome machinery (5, 20).
This work was supported by the Sonderforschungsbereich 464 (Teilprojekt B6) of the Deutsche Forschungsgemeinschaft.
Vaccinia virus recombinants were provided by M. Esteban, and monoclonal
antibody 1577 was provided by M. Ferguson through courtesy of the
NIBSC/MRC AIDS Reagent Project. We thank H. Ziegler for advice and
reading of the manuscript.
| 1.
|
Andre, S.,
B. Seed,
J. Eberle,
W. Schraut,
A. Bultmann, and J. Haas.
1998.
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage.
J. Virol.
72:1497-1503[Abstract/Free Full Text].
|
| 2.
|
Arthur, L. O.,
J. W. Bess, Jr.,
R. C. Sowder,
R. E. Benveniste,
D. L. Mann,
J. C. Chermann, and L. E. Henderson.
1992.
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines.
Science
258:1935-1938[Abstract/Free Full Text].
|
| 3.
|
Biederer, T.,
C. Volkwein, and T. Sommer.
1996.
Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway.
EMBO J.
15:2069-2076[Medline].
|
| 4.
|
Biederer, T.,
C. Volkwein, and T. Sommer.
1997.
Role of Cue1p in ubiquitination and degradation at the ER surface.
Science
278:1806-1809[Abstract/Free Full Text].
|
| 5.
|
Brandimarti, R., and B. Roizman.
1997.
Us9, a stable lysine-less herpes simplex virus 1 protein, is ubiquitinated before packaging into virions and associates with proteasomes.
Proc. Natl. Acad. Sci. USA
94:13973-13978[Abstract/Free Full Text].
|
| 6.
|
Breitschopf, K.,
E. Bengal,
T. Ziv,
A. Admon, and A. Ciechanover.
1998.
A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein.
EMBO J.
17:5964-5973[CrossRef][Medline].
|
| 7.
|
Ciechanover, A.
1994.
The ubiquitin-proteasome proteolytic pathway.
Cell
79:13-21[CrossRef][Medline].
|
| 8.
|
Crise, B.,
L. Buonocore, and J. K. Rose.
1990.
CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.
J. Virol.
64:5585-5593[Abstract/Free Full Text].
|
| 9.
|
Earl, P. L.,
B. Moss, and R. W. Doms.
1991.
Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein.
J. Virol.
65:2047-2055[Abstract/Free Full Text].
|
| 10.
|
Hammond, C., and A. Helenius.
1995.
Quality control in the secretory pathway.
Curr. Opin. Cell Biol.
7:523-529[CrossRef][Medline].
|
| 11.
|
Jentsch, S., and S. Schlenker.
1995.
Selective protein degradation: a journey's end within the proteasome.
Cell
82:881-884[CrossRef][Medline].
|
| 12.
|
Joslin, G.,
W. Hafeez, and D. H. Perlmutter.
1991.
Expression of stress proteins in human mononuclear phagocytes.
J. Immunol.
147:1614-1620[Abstract].
|
| 13.
|
Kantanen, M. L.,
P. Leinikki, and E. Kuismanen.
1995.
Endoproteolytic cleavage of HIV-1 gp160 envelope precursor occurs after exit from the trans-Golgi network (TGN).
Arch. Virol.
140:1441-1449[CrossRef][Medline].
|
| 14.
|
Kimura, T.,
M. Nishikawa, and J. Fujisawa.
1996.
Uncleaved env gp160 of human immunodeficiency virus type 1 is degraded within the Golgi apparatus but not lysosomes in COS-1 cells.
FEBS Lett.
390:15-20[CrossRef][Medline].
|
| 15.
|
Kopito, R. R.
1997.
ER quality control: the cytoplasmic connection.
Cell
88:427-430[CrossRef][Medline].
|
| 16.
|
Li, Y.,
J. J. Bergeron,
L. Luo,
W. J. Ou,
D. Y. Thomas, and C. Y. Kang.
1996.
Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport.
Proc. Natl. Acad. Sci. USA
93:9606-9611[Abstract/Free Full Text].
|
| 17.
|
Mayer, T. U.,
T. Braun, and S. Jentsch.
1998.
Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein.
EMBO J.
17:3251-3257[CrossRef][Medline].
|
| 18.
|
Meerovitch, K.,
S. Wing, and D. Goltzman.
1998.
Proparathyroid hormone-related protein is associated with the chaperone protein BiP and undergoes proteasome-mediated degradation.
J. Biol. Chem.
273:21025-21030[Abstract/Free Full Text].
|
| 19.
|
Merkle, R. K.,
D. E. Helland,
J. L. Welles,
A. Shilatifard,
W. A. Haseltine, and R. D. Cummings.
1991.
gp160 of HIV-1 synthesized by persistently infected Molt-3 cells is terminally glycosylated: evidence that cleavage of gp160 occurs subsequent to oligosaccharide processing.
Arch. Biochem. Biophys.
290:248-257[CrossRef][Medline].
|
| 20.
|
Ott, D. E.,
L. V. Coren,
T. D. Copeland,
B. P. Kane,
D. G. Johnson,
R. C. Sowder,
Y. Yoshinaka,
S. Oroszlan,
L. O. Arthur, and L. E. Henderson.
1998.
Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus.
J. Virol.
72:2962-2968[Abstract/Free Full Text].
|
| 21.
|
Otteken, A., and B. Moss.
1996.
Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin.
J. Biol. Chem.
271:97-103[Abstract/Free Full Text].
|
| 22.
|
Pfeiffer, T.,
H. Zentgraf,
B. Freyaldenhoven, and V. Bosch.
1997.
Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the cellular site of virus particle budding.
J. Gen. Virol.
78:1745-1753[Abstract].
|
| 23.
|
Plemper, R. K.,
S. Bohmler,
J. Bordallo,
T. Sommer, and D. H. Wolf.
1997.
Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation.
Nature
388:891-895[CrossRef][Medline].
|
| 24.
|
Plemper, R. K.,
R. Egner,
K. Kuchler, and D. H. Wolf.
1998.
Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome.
J. Biol. Chem.
273:32848-32856[Abstract/Free Full Text].
|
| 25.
|
Raja, N. U.,
M. J. Vincent, and M. A. Jabbar.
1993.
Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
J. Gen. Virol.
74:2085-2097[Abstract/Free Full Text].
|
| 26.
|
Salzwedel, K.,
J. T. West, Jr.,
M. J. Mulligan, and E. Hunter.
1998.
Retention of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum does not redirect virus assembly from the plasma membrane.
J. Virol.
72:7523-7531[Abstract/Free Full Text].
|
| 27.
|
Stein, B. S., and E. G. Engleman.
1990.
Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex.
J. Biol. Chem.
265:2640-2649[Abstract/Free Full Text].
|
| 28.
|
Ward, C. L.,
S. Omura, and R. R. Kopito.
1995.
Degradation of CFTR by the ubiquitin-proteasome pathway.
Cell
83:121-127[CrossRef][Medline].
|
| 29.
|
West, M. H., and W. M. Bonner.
1980.
Histone 2B can be modified by the attachment of ubiquitin.
Nucleic Acids Res.
8:4671-4680[Abstract/Free Full Text].
|
| 30.
|
Wiertz, E. J.,
D. Tortorella,
M. Bogyo,
J. Yu,
W. Mothes,
T. R. Jones,
T. A. Rapoport, and H. L. Ploegh.
1996.
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.
Nature
384:432-438[CrossRef][Medline].
|
| 31.
|
Willey, R. L.,
J. S. Bonifacino,
B. J. Potts,
M. A. Martin, and R. D. Klausner.
1988.
Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
Proc. Natl. Acad. Sci. USA
85:9580-9584[Abstract/Free Full Text].
|